HLA
LOXO

Hamilton Lane Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Hamilton Lane Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-18,297
Closed -$588K – 77
2016
Q4 		$588K Buy
18,297
+9,208
+101% +$236K 0.39% 44
2016
Q3 		$238K Buy
+9,089
New +$238K 0.12% 57

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hamilton Lane Advisors's LOXO Position: Q1 2017 in Review

Hamilton Lane Advisors sold out of Loxo Oncology, Inc (LOXO) in Q1 2017, closing a stake of 18,297 shares — an estimated $588K sold.

Hamilton Lane Advisors first reported a position in LOXO in Q3 2016 and held it in 2 quarters. The position peaked at $588K in Q4 2016. 86 funds tracked by Wall St. Rank hold LOXO as of Q1 2017.

  • Hamilton Lane Advisors reported no remaining Loxo Oncology, Inc position as of Q1 2017 after selling out during the quarter.
  • Hamilton Lane Advisors sold 18,297 Loxo Oncology, Inc shares in Q1 2017, an estimated $588K.
  • Hamilton Lane Advisors first reported a position in Loxo Oncology, Inc in Q3 2016 and held it in 2 quarters.
  • Hamilton Lane Advisors's Loxo Oncology, Inc position peaked at $588K in Q4 2016.
  • 86 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2017.

Based on Hamilton Lane Advisors's 13F filing for Q1 2017, filed 24 Apr 2017.